
Aitiologic
AI-powered precision medicine solutions for early disease detection and targeted therapy.
Date | Investors | Amount | Round |
---|---|---|---|
* | €2.5m | Early VC | |
Total Funding | 000k |
Related Content
Aitiologic is an Austrian precision medicine startup focused on developing AI-powered solutions for early disease detection and targeted therapy. The company leverages patented multi-omics technology, originally invented at Siemens Healthineers, to decode health at the molecular level. Aitiologic collaborates with global diagnostics companies and is supported by the Austrian Promotional Bank AWS. The business model centers on creating partnerships and licensing its technology to healthcare providers and diagnostics firms, aiming to enhance patient outcomes through precise medical interventions. The startup operates in the healthcare and biotechnology markets, serving clients who require advanced diagnostic tools and personalized treatment options. Aitiologic generates revenue through technology licensing and strategic collaborations.
Keywords: precision medicine, AI solutions, early detection, targeted therapy, multi-omics, healthcare, diagnostics, molecular health, biotechnology, partnerships